Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations

v3.22.2
Discontinued Operations
6 Months Ended
Jun. 30, 2022
Discontinued Operations  
Discontinued Operations

7.    Discontinued Operations

The following table presents information related to assets and liabilities reported as discontinued operations in our condensed balance sheet:

June 30, 

    

December 31,

    

2022

    

2021

(In thousands)

  

 

  

Prepaid expenses and other current assets

$

14

$

12

Discontinued operations – current assets

$

14

$

12

Accounts payable

$

769

$

782

Accrued clinical trials expenses

 

1

 

Other accrued liabilities

 

362

 

362

Discontinued operations – current liabilities

$

1,132

$

1,144